LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Non-Hodgin's lymphoma is curable in 76% of patients. In nonlymphoblastic lymphmas, cancer may
return on average 3 months from beginning treatment and for lymphoblastic lymphomas, 6
months. To aggressively treat this cancer this study uses effective drugs in three parts:
- Induction ends on day 19
- Consolidation ends on day 38 or 42
- Maintenance may include up to 6 cycles